PCA
NSPR icon

Pallas Capital Advisors’s InspireMD NSPR Stock Holding History

Pallas Capital Advisors’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.7K Sell
11,000
-2,000
-15% -$2.12K ﹤0.01% 1027
2026
Q1 		$21.2K Buy
13,000
+2,000
+18% +$3.41K ﹤0.01% 851
2025
Q4 		$19.6K Hold
11,000
– – ﹤0.01% 880
2025
Q3 		$26.5K Buy
+11,000
New +$26.7K ﹤0.01% 864

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
AF
Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return

Pallas Capital Advisors's NSPR Position: Q2 2026 in Review

Pallas Capital Advisors reduced its InspireMD (NSPR) stake by 15% in Q2 2026, selling an estimated $2.12K and leaving 11,000 shares worth $7.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1027.

Pallas Capital Advisors first reported a position in NSPR in Q3 2025 and has held it in 4 quarters since. The position peaked at $26.5K in Q3 2025. 37 funds tracked by Wall St. Rank hold NSPR as of Q2 2026.

  • Pallas Capital Advisors held 11,000 shares of InspireMD worth $7.7K as of Q2 2026.
  • Pallas Capital Advisors sold 2,000 InspireMD shares in Q2 2026, an estimated $2.12K.
  • InspireMD made up ﹤0.01% of Pallas Capital Advisors's portfolio in Q2 2026, its #1027 holding.
  • Pallas Capital Advisors first reported a position in InspireMD in Q3 2025 and has held it in 4 quarters since.
  • Pallas Capital Advisors's InspireMD position peaked at $26.5K in Q3 2025.
  • 37 funds tracked by Wall St. Rank held InspireMD as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.